Jack W. Callicutt
2015
In 2015, Jack W. Callicutt earned a total compensation of $425.9K as Chief Financial Officer at Galectin Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $69,120 |
|---|---|
| Option Awards | $72,377 |
| Salary | $240,000 |
| Other | $44,419 |
| Total | $425,916 |
Callicutt received $240K in salary, accounting for 56% of the total pay in 2015.
Callicutt also received $69.1K in bonus, $72.4K in option awards and $44.4K in other compensation.
Rankings
In 2015, Jack W. Callicutt's compensation ranked 11,386th out of 13,638 executives tracked by ExecPay. In other words, Callicutt earned more than 16.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,386 out of 13,638 | 17th |
Division Manufacturing | 4,358 out of 5,187 | 16th |
Major group Chemicals And Allied Products | 1,605 out of 1,857 | 14th |
Industry group Drugs | 1,325 out of 1,531 | 14th |
Industry Pharmaceutical Preparations | 1,024 out of 1,179 | 13th |
Source: SEC filing on November 7, 2017.
Callicutt's colleagues
We found three more compensation records of executives who worked with Jack W. Callicutt at Galectin Therapeutics in 2015.